(Q28190975)

1

0 references

L A Cheryk

2

0 references

A Durocher

3

0 references

A Bruno

4

0 references

N U Bang

5

0 references

J D Fleck

6

0 references

L Williams

7

0 references

J Biller

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

8

0 references

language of work or name

English

0 references

publication date

2 November 2001

0 references

published in

Neuroscience Letters

0 references

volume

313

0 references

issue

1-2

0 references

page(s)

88-92

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Hemostatic Disturbances in Acute Ischemic Stroke: A Study of 86 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Paired analysis of urinary thromboxane B2 metabolites in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Protein C activation in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Prognostic significance of fibrinopeptide A in survivors of cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Platelet Activation Is Not Involved in Acceleration of the Coagulation System in Acute Cardioembolic Stroke With Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Enhanced in vivo platelet activation in subtypes of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Markers of a hypercoagulable state following acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021

Platelet activation and lipid peroxidation in patients with acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902260-1

7 January 2021